Concurrent tobacco and cannabis use is associated with increased odds of internalizing and externalizing problems among US adolescents.

Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price.

Waitlist mortality may be attenuated with refinements to the current allocation system among pediatric patients with heart transplant status 1A.

Metformin reduced the chances of worse IBD outcomes among individuals with concurrent type 2 diabetes and IBD.

Increasing high-sensitivity C-reactive protein levels over time are associated with increased risk for incident HF in Black adults.

Investigators found socioeconomic disparities in mental health outcomes among children and adolescents during the COVID-19 pandemic.

A meta-analysis of 9 studies revealed that overall survival is reduced for patients without obesity receiving bevacizumab plus chemotherapy for mCRC.

A scientific statement has been published by the American Heart Association regarding the cardiovascular management of aortopathy in children.

The FINEARTS-HF study evaluated the safety and efficacy of finerenone in patients with symptomatic HF with a left ventricular ejection fraction greater than or equal to 40%.

Nonadherence to medication in patients with HFrEF is associated with less improvement and worse health status.

On Monday, the U.S. Food and Drug Administration approved the Insulet Omnipod 5 insulin delivery system for patients with type 2 diabetes.

Depressive symptom severity in patients recently hospitalized for decompensated HFrEF is associated with subjective perceptions of functional ability.